Researcher
Evelien Vanderlinden
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 2006 → Today
Projects
1 - 2 of 2
- Elucidation of the mechanism of action of novel HTLV-1 inhibitors: a step-by-step approachFrom21 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Characterization of the influenza virus polymerase using T-705 and ribavirin and design of RNA chain terminating prodrugs of these unique antiviral agentsFrom1 Jan 2015 → 31 Dec 2017Funding: FWO research grant KAN
Publications
1 - 10 of 36
- PRO-2000 exhibits SARS-CoV-2 antiviral activity by interfering with spike-heparin binding(2023)
Authors: Evelien Vanderlinden, Arnaud Boonen, Sam Noppen, Maya Imbrechts, Robert Snoeck, Annelies Stevaert, Lieve Naesens, Graciela Andrei, Dominique Schols
- Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation(2022)
Authors: Tim Dierckx, Evelien Vanderlinden, Dominique Schols, Dirk Daelemans, Jurgen Vercauteren, Johan Van Weyenbergh
- Synthesis and structure-activity relationship of L-methionine-coupled 1,3,4-thiadiazole derivatives with activity against influenza virus(2022)
Authors: Evelien Vanderlinden, Lieve Naesens
Pages: 398 - 415 - A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin(2021)
Authors: Evelien Vanderlinden, Lieve Naesens
- Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues(2021)
Authors: Evelien Vanderlinden, Laura Vangeel, Xinyu Wang, Shi-Yan Caroline Foo, Pieter Leyssen, Johan Neyts, Dirk Jochmans, Dominique Schols, Steven De Jonghe
- Favipiravir Does Not Inhibit Chikungunya Virus Replication in Mosquito Cells and Aedes aegypti Mosquitoes(2021)
Authors: Sofie Jacobs, Evelien Vanderlinden, Lieve Naesens, Leen Delang
- In Vitro Characterization of the Carbohydrate-Binding Agents HHA, GNA, and UDA as Inhibitors of Influenza A and B Virus Replication(2021)
Authors: Evelien Vanderlinden, Lieve Naesens, Dominique Schols
- N-benzyl 4,4-disubstituted piperidines as a potent class of influenza H1N1 virus inhibitors showing a novel mechanism of hemagglutinin fusion peptide interaction(2020)
Authors: Evelien Vanderlinden, Manon Laporte, Annelies Stevaert, Lieve Naesens
- Superior inhibition of influenza virus hemagglutinin-mediated fusion by indole-substituted spirothiazolidinones(2020)
Authors: Evelien Vanderlinden, Lieve Naesens
- Novel N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives as potent and selective influenza virus fusion inhibitors(2019)
Authors: Evelien Vanderlinden, Lieve Naesens